Showing results (221-230 of 522) with videos related to
Sort By:
Pageof 53
Heart Rhythm|September 5, 2021
Skin sympathetic nerve activity as a biomarker of fitnessXiao Liu, Awaneesh Kumar, Joseph O'Neil, et al.Journal of Biomedical Nanotechnology|November 12, 2015
Topical Skin Cancer Therapy Using Doxorubicin-Loaded Cationic Lipid Nanoparticles and lontophoresisLucas A Huber, Tatiana A Pereira, Danielle N Ramos, et al.HIV Medicine|February 26, 2015
Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialS Sharma, A G Babiker, S Emery, et al.Arzneimittel-Forschung|February 24, 2001
Chemical reactivity studies with naphthoquinones from Tabebuia with anti-trypanosomal efficacyC N Pinto, A P Dantas, K C De Moura, et al.HIV Medicine|April 17, 2014
A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapyA D Revell, M A Boyd, D Wang, et al.European Journal of Medicinal Chemistry|July 9, 2004
Studies on the trypanocidal activity of semi-synthetic pyran[b-4,3]naphtho[1,2-d]imidazoles from beta-lapachoneKelly C G De Moura, Kelly Salomão, Rubem F S Menna-Barreto, et al.European Journal of Medicinal Chemistry|February 19, 2019
Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenaseFelipe A Calil, Juliana S David, Estela R C Chiappetta, et al.European Journal of Sport Science|March 21, 2022
Abnormal exercise adaptation after varying severities of COVID-19: A controlled cross-sectional analysis of 392 survivorsFabrício Braga, Fernanda Domecg, Marcelo Kalichsztein, et al.Chemmedchem|October 20, 2020
Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against TrypanosomiasesDaniel G Silva, Anna Junker, Shaiani M G de Melo, et al.Journal of Clinical Microbiology|July 6, 2000
Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from KenyaS Emery, S Bodrug, B A Richardson, et al.Pageof 53